Remepy Reports Strong Hybridopa Parkinson’s Trial Data
NEW YORK, N.Y., May 20, 2026 Remepy has announced positive results from its Phase IIa clinical trial evaluating Hybridopa™,...
AI medical devices
Advertisement
Optimi Health Prices $15M Nasdaq Uplisting Offering
VANCOUVER, British Columbia, May 20, 2026 Optimi Health Corp. has announced the pricing of an oversubscribed US$15 million underwritten...
Paragon Institute Proposes Safer Future for AI Medical Devices
BOSTON, Mass., May 20, 2026 The Paragon Institute has released a new scientific proposal highlighting the growing risks associated...
Clarius Achieves FDA AI Milestones and Profitable Growth
VANCOUVER, BC, Dec. 17, 2025 — Clarius Mobile Health, a global leader in AI-powered handheld ultrasound technology, reported a...
Advertisement
